How is HIV/AIDS surveillance conducted?

HIV surveillance is a systematic, ongoing process designed to collect, analyze, interpret, and disseminate data on HIV infection trends, risk behaviors, prevention service coverage, and treatment outcomes within a population. It serves as the foundation for evidence-based public health planning, resource allocation, and program evaluation. Surveillance typically includes both case-based reporting—where diagnosed HIV infections are confidentially reported to national or regional health authorities—and population-level monitoring through representative surveys (e.g., antenatal clinic sentinel surveillance, household-based behavioral and biological surveys). Laboratory-based surveillance tracks key indicators such as CD4 counts, viral load suppression rates, drug resistance patterns, and late presentation (e.g., AIDS-defining illness at diagnosis). In recent years, molecular surveillance using HIV genetic sequencing has been increasingly integrated to identify transmission clusters and guide targeted interventions. Ethical considerations—including informed consent, confidentiality, data security, and community engagement—are integral to all phases of HIV surveillance. Importantly, surveillance systems must be adaptable, equitable, and inclusive—ensuring representation of key populations (e.g., men who have sex with men, people who inject drugs, sex workers, transgender individuals) often disproportionately affected by HIV but historically underrepresented in routine data collection.